Health and safety is our priority.
JPM22 aims to bring together more than 180 decision-makers and key players from academic and clinical research, start-ups, biotechs and pharmaceutical industries to discuss the challenges of the therapeutic potential of the microbiome.
The day is held from 14 to 15 December.